Literature DB >> 6725793

Successful treatment of chronic idiopathic urticaria and angioedema with cimetidine alone.

J Farnam, J A Grant, B G Guernsey, J L Jorizzo, E R Petrusa.   

Abstract

We have studied a 50-year-old white man with chronic urticaria and angioedema who has responded to treatment with cimetidine alone for over 2 yr. In a double-blind, placebo-controlled study, cimetidine alone was at least as effective as chlorpheniramine in relief of urticaria and angioedema. Additionally, cimetidine significantly inhibited (p less than 0.01) the wheal response to histamine when it was compared to placebo. The inhibition of wheal response to histamine by cimetidine was significantly higher (p less than 0.05) than chlorpheniramine. The presence of predominantly H2- rather than H1-histamine receptors in the cutaneous blood vessels may be responsible for the therapeutic effects of cimetidine in this patient.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6725793     DOI: 10.1016/0091-6749(84)90457-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  5 in total

1.  Histamine response and local cooling in the human skin: involvement of H1- and H2-receptors.

Authors:  M Grossmann; M J Jamieson; W Kirch
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

Review 2.  Histamine2 (H2)-receptor antagonists in the treatment of urticaria.

Authors:  T C Theoharides
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

3.  Effect of terfenadine and ranitidine on histamine and suxamethonium wheals.

Authors:  E Paul; M Pfeffer; R H Bödeker
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 4.  Urticaria. Recognition, causes and treatment.

Authors:  A D Ormerod
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

Review 5.  Guideline of Chronic Urticaria Beyond.

Authors:  Lauren M Fine; Jonathan A Bernstein
Journal:  Allergy Asthma Immunol Res       Date:  2016-09       Impact factor: 5.764

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.